Intercept Pharmaceuticals, Inc. (ICPT)

ICPT was delisted on the 7th of November, 2023.

• Market cap: $795M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.

Employees: 341